Stablix Inc
Advertisement
Stablix Inc is a pioneering biotechnology company based in New York City and Boston, dedicated to developing transformative medicines for patients with unmet medical needs. With a multidisciplinary team of scientists and innovators, Stablix is at the forefront of targeted deubiquitination therapeutics, utilizing a powerful small-molecule modality to address a wide range of devastating diseases.
Through their innovative RESTORED platform, Stablix is revolutionizing the approach to diverse diseases by harnessing the body's own cellular machinery. Their heterobifunctional small molecules selectively recruit active deubiquitinases to precisely remove ubiquitin from target proteins, potentially restoring deficient proteins to therapeutic levels. With a focus on rare diseases, cancer, and immunological disorders, Stablix is driving forward groundbreaking advancements in the field of targeted protein stabilization therapeutics.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
